Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formulary

 07 Jan 2025 02:13 PM

Zydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to CVS’s template formulary starting January 1, 2025. This collaboration validates Zydus' new drug applications portfolio and aims to improve access to high-quality medications for patients.

Zydus Lifesciences gets WHO prequalification for Typhoid Vi conjugate vaccine

 23 Oct 2024 11:30 AM

Zydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV. Eligible for UN procurement, the vaccine targets 6-month to 65-year-olds and addresses high typhoid incidence in India, Africa, and Southeast Asia.

Zydus gets WHO nod for its typhoid vaccine

 23 Oct 2024 11:30 AM

Zydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV. Eligible for UN procurement, the vaccine targets 6-month to 65-year-olds and addresses high typhoid incidence in India, Africa, and Southeast Asia.